Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF

Translate this page into:

Letter to the Editor - Study Letter
2018:84:4;458-460
doi: 10.4103/ijdvl.IJDVL_41_17
PMID: 29770785

Anti-pruritic efficacies of doxycycline and erythromycin in the treatment of acne vulgaris: A randomized single-blinded pilot study

Taige Cao1 , Eugene Sern-Ting Tan1 , Yiong Huak Chan2 , Gil Yosipovitch3 , Hong Liang Tey4
1 National Skin Centre, Singapore
2 Biostatistics Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
3 Department of Dermatology and Cutaneous Surgery, University of Miami Health System, USA
4 National Skin Centre; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore

Correspondence Address:
Hong Liang Tey
1 Mandalay Road, Singapore - 308205
Singapore
Published: 17-May-2018
How to cite this article:
Cao T, Tan ES, Chan YH, Yosipovitch G, Tey HL. Anti-pruritic efficacies of doxycycline and erythromycin in the treatment of acne vulgaris: A randomized single-blinded pilot study. Indian J Dermatol Venereol Leprol 2018;84:458-460
Copyright: (C)2018 Indian Journal of Dermatology, Venereology, and Leprology

Sir,

Pruritus is a significant symptom that is frequently experienced by patients with acne vulgaris and contributes significantly to patients' morbidity.[1],[2] In our clinical experience, pruritus in acne vulgaris can be effectively reduced with systemic antibiotics, such as doxycycline and erythromycin, which are commonly used as first-line systemic acne medications. However, it is not known if this effect results from a decrease in inflammation alone or if there are additional anti-pruritic effects mediated by the antibiotics. A study on human keratinocytes demonstrated that tetracycline attenuates the protease-activated receptor 2 interleukin-8 axis in the modulation of proinflammatory responses.[3] This effect was not observed in the macrolides, including erythromycin and clarithromycin.[4] Because protease-activated receptor 2 has been shown by multiple studies to be an important itch receptor, doxycycline may possibly have a greater efficacy in relieving itch through the inhibition of protease-activated receptor 2, as compared to erythromycin.

The aim of this randomized single-blinded pilot trial was to evaluate the anti-pruritic efficacies of doxycycline and erythromycin in the treatment of acne vulgaris. Approval for the study was obtained from the National Healthcare Group Ethics Review Board and Health Sciences Authority, Singapore.

Patients with mild-to-moderate acne based on the Comprehensive Acne Severity Scale [Figure - 1] and [Figure - 2] and associated itch intensity of more than 2 on a 10-point numerical scale were recruited from the dermatology clinics at the National Skin Centre in Singapore.[5] Subjects were randomized to receive either oral doxycycline 100 mg daily or erythromycin 500 mg b.d. for 6 weeks. All subjects were instructed to stop the application of any topical agents during this period and to use the same type of mild cleanser (QV wash®) for facial washing up to a maximum of three times a day. At baseline and 6 weeks after treatment, an itch questionnaire was administered;[6] which included the average itch intensity over the prior 1 week on a 10-point numerical scale, frequency of itch (graded 1–7, ranging from 1 episode a month to more than 10 episodes daily) and itch quality-of-life assessment (16 questions, each graded 1–6 ranging from not affected to severely affected, giving a total score of 16–96). The severity of acne was also graded by a dermatologist blinded to the treatment arm (graded 0–5 on the Comprehensive Acne Severity Scale [Figure - 3], from clear to very severe) at baseline and at 6 weeks. Analyses were performed on a per-protocol basis using the paired t-test (for within-group comparisons) and two-sample t-test (for between-groups comparisons).

Figure 1: Grade 2 (mild in severity) acne based on Comprehensive Acne Severity Scale. Easily recognizable, less than half affected area involved. Many comedones, papules and pustules
Figure 2: Grade 3 (moderate in severity) acne based on Comprehensive Acne Severity Scale. More than half affected area involved. Numerous comedones, papules and pustules
Figure 3: Acne quality-of-life questionnaire

Thirty-six subjects were recruited, of whom 29 completed the study and 7 were lost to follow-up. Of the 29 subjects, 14 received erythromycin, while 15 received doxycycline. Both groups had comparable baseline characteristics [Table - 1]. Grading of acne severity [Table - 2] significantly improved in both groups (P< 0.01), and there was no significant difference between the two treatment arms (P = 0.29). Subjects in the doxycycline group experienced a significant reduction in itch intensity scores at 6 weeks (P = 0.03) and this remained significant after adjusting for improvement in acne grading (P = 0.02). The reduction in itch intensity scores was not statistically significant in the erythromycin group (P = 0.11). Comparing the efficacies of doxycycline and erythromycin in reducing itch intensity scores, the difference was not statistically significant (P = 0.42). The itch quality-of-life scores were significantly better in both groups (P = 0.03), but the frequency of itch was not much different.

Table 1: Baseline characteristics of 29 subjects who completed the study
Table 2: Differences in scores after 6 weeks treatments with doxycycline and erythromycin

We were unable to find any previous reports of the anti-pruritic efficacies of systemic antibiotics in the treatment of acne. Doxycycline was found to significantly reduce pruritus in acne vulgaris and we postulate that in addition to a reduction in inflammation, attenuation of the protease-activated receptor 2 interleukin-8 pathway may contribute to this effect. A limitation of this study is the relatively high dropout rate (19%). Sample size is very small. Other factors like age of the patient, other comorbidities and general skin condition have not been taken into consideration.

In conclusion, our results revealed that doxycycline effectively reduces itch intensity in pruritic acne and this effect was independent of improvements in acne severity. Doxycycline may serve as a good antibiotic option for patients who experience itch in their acne lesions.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References
1.
Reich A, Trybucka K, Tracinska A, Samotij D, Jasiuk B, Srama M, et al. Acne itch: Do acne patients suffer from itching? Acta Derm Venereol 2008;88:38-42.
[Google Scholar]
2.
Lim YL, Chan YH, Yosipovitch G, Greaves MW. Pruritus is a common and significant symptom of acne. J Eur Acad Dermatol Venereol 2008;22:1332-6.
[Google Scholar]
3.
Ishikawa C, Tsuda T, Konishi H, Nakagawa N, Yamanishi K. Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes. Antimicrob Agents Chemother 2009;53:1760-5.
[Google Scholar]
4.
Tsuda T, Ishikawa C, Konishi H, Hayashi Y, Nakagawa N, Matsuki M, et al. Effect of 14-membered-ring macrolides on production of interleukin-8 mediated by protease-activated receptor 2 in human keratinocytes. Antimicrob Agents Chemother 2008;52:1538-41.
[Google Scholar]
5.
Tan JK, Tang J, Fung K, Gupta AK, Thomas DR, Sapra S, et al. Prevalence and severity of facial and truncal acne in a referral cohort. J Drugs Dermatol 2008;7:551-6.
[Google Scholar]
6.
Yosipovitch G, Zucker I, Boner G, Gafter U, Shapira Y, David M, et al. Aquestionnaire for the assessment of pruritus: Validation in uremic patients. Acta Derm Venereol 2001;81:108-11.
[Google Scholar]

Fulltext Views
674

PDF downloads
217
Show Sections